Favipiravir CAS 259793-96-9 T-705 Ubunyulu ≥99.0% (HPLC) COVID-19 API Factory High Quality Featured Image Featured

IFavipiravir CAS 259793-96-9 T-705 Ubunyulu ≥99.0% (HPLC) COVID-19 API Factory High Quality

Inkcazelo emfutshane:

Igama leMichiza: Favipiravir;T-705

CAS: 259793-96-9

Imbonakalo: Mhlophe ukuya kwi-Off-White Powder

Ubunyulu: ≥99.0% (HPLC)

Kunyango lweNtsholongwane yoMkhuhlane kunye ne-COVID-19

Umgangatho ophezulu we-API, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Umenzi onobunyulu obuPhezulu kunye noMgangatho oZinzile
Ubonelelo ngezoRhwebo lweFavipiravir kunye nabaPhakathi abaNxulumeneyo:
IFavipiravir CAS 259793-96-9
I-2-Aminopropanediamide CAS 62009-47-6
I-Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
I-6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
I-6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
I-3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Iipropati zeMichiza:

Igama leMchiza	IFavipiravir
Izithethantonye	T-705;I-6-Fluoro-3-Hydroxy-2-Pyrazinecarboxamide
Inombolo yeCAS	259793-96-9
Inombolo yeCAT	RF-API18
Ubume beStokhwe	Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram
Ifomula yeemolekyuli	C5H4FN3O2
Ubunzima beMolekyuli	157.1
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Mhlophe ukuya kwi-Off-White Powder
Ukuchongwa kwe-1H-NMR	Iyahambelana nesakhiwo esicetywayo
Ukuchongwa kwe-HPLC	Ixesha lokugcinwa kwencopho ephambili kulungiselelo lwesampulu kufuneka lihambelane nexesha lokugcinwa kwencopho ephambili kulungiselelo lomgangatho wereferensi.
Isazisi Mass	I-Mass Spectrum iyahambelana nesakhiwo esicetywayo
Indawo yokunyibilika	188.0℃-193.0℃
Izinto ezinxulumeneyo (Uhlengahlengiso lweNdawo)	Nakuphi na Ukungcola Okukodwa: ≤0.10% (HPLC)
Izinto ezinxulumeneyo (Uhlengahlengiso lweNdawo)	Ukungcola ngokupheleleyo: ≤1.0% (HPLC)
Ubunyulu / Indlela yokuHlalutya	≥99.0% (HPLC)
Ukufuma (KF)	≤0.50%
Intsalela kwi-Ignition	≤0.10%
Iintsimbi ezinzima	≤20ppm
Intsalela yezinyibilikisi
IMethanol	≤3000ppm
Isopropanol	≤5000ppm
n-Heptane	≤5000ppm
I-Ethanol	≤5000ppm
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	I-Active Pharmaceutical Ingredient (API);Unyango lwe-COVID-19

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

FAQ:

Isicelo:

I-Favipiravir (T-705) (CAS 259793-96-9) yenye yeekhompawundi ezi-5 ezicetyiswa yi-WHO kuphando lonyango lwe-COVID-19.I-Favipiravir sisithinteli esikhethiweyo se-RNA exhomekeke kwi-RNA polymerase esebenza ngokuchasene neentsholongwane ezininzi ze-RNA, iintsholongwane zomkhuhlane, intsholongwane ye-West Nile, intsholongwane ye-yellow fever, intsholongwane yesifo sonyawo kunye nomlomo kunye nezinye ii-flaviviruses, i-arenaviruses, i-bunyaviruses kunye ne-alphaviruses.I-Favipiravir lichiza elilwa nentsholongwane ebanzi elaye lacinywa nguMlawuli Jikelele we-India (DCGI) kwiveki ephelileyo ukusetyenziswa “kuthintelo olungxamisekileyo” phakathi kwabaguli be-Covid-19.IFavipiravir yaveliswa ekupheleni kweminyaka yoo-1990 yinkampani eyathi kamva yathengwa yifem yaseJapan iFujifilm njengenxalenye yotshintsho lwayo ukusuka kwishishini leefoto ukuya kukhathalelo lwempilo.Emva kokuvavanywa ngokuchasene noluhlu lweentsholongwane, ichiza lamkelwa eJapan ngo-2014 ukuze lisetyenziswe ngokukhawuleza ngokuchasene nobhubhane lomkhuhlane okanye ukunyanga iintlobo ezintsha zomkhuhlane.